Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01626950
What this trial is testing

Living Conditions and Breast Cancer

Who this might be right for
Breast Neoplasms
Centre Hospitalier Universitaire de Nīmes 684
Testing effectiveness (Phase 2)WithdrawnNCT00227474
What this trial is testing

S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Not applicableLooking for participantsNCT06371274
What this trial is testing

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Who this might be right for
Triple-negative Breast Cancer
First Affiliated Hospital of Zhejiang University 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824
What this trial is testing

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases, Adult
Colette Shen 41
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Not applicableWithdrawnNCT04020523
What this trial is testing

Advanced MR Techniques for Breast Cancer Detection

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT00490646
What this trial is testing

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
R-Pharm 50
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)Looking for participantsNCT04468061
What this trial is testing

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Who this might be right for
Breast CancerTriple Negative Breast CancerPD-L1 Negative
Dana-Farber Cancer Institute 110
Large-scale testing (Phase 3)Study completedNCT00026286
What this trial is testing

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms
Eastern Cooperative Oncology Group
Early research (Phase 1)WithdrawnNCT05774886
What this trial is testing

Implantable Microdevice for TNBC - Pilot Study

Who this might be right for
Triple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+4 more
Dana-Farber Cancer Institute
Not applicableActive Not RecruitingNCT05571618
What this trial is testing

The Rechallenge of ADCs in MBC Patients

Who this might be right for
Breast Cancer
Fudan University 100
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Not applicableEnded earlyNCT00156260
What this trial is testing

Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 88
Not applicableNot Yet RecruitingNCT07246720
What this trial is testing

IPP-PSP Block vs. SPSIPB in Breast Surgery

Who this might be right for
Postoperative Acute PainBreast CancerRegional Anesthesia
Zonguldak Bulent Ecevit University 70
Testing effectiveness (Phase 2)Ended earlyNCT00496379
What this trial is testing

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Who this might be right for
Breast CancerCNS Disease
Nancy Lin, MD 15
Testing effectiveness (Phase 2)Study completedNCT02536742
What this trial is testing

Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 124
Early research (Phase 1)Study completedNCT01513083
What this trial is testing

Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Who this might be right for
Breast Cancer
Hoffmann-La Roche 28
Testing effectiveness (Phase 2)Ended earlyNCT00632541
What this trial is testing

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hoosier Cancer Research Network 18
Not applicableEnded earlyNCT05289466
What this trial is testing

Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.

Who this might be right for
IORT-Intra-Operative Radiation Therapy
Saint John's Cancer Institute 5
Next Page